Income StatementBalance SheetCash FlowSegments
MAN

Veradermics Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Veradermics holds $397.4M in total assets. Cash and equivalents total $168.4M. The current ratio is 59.12.

Total Assets$397.4MTotal Stockholders Equity$390.6MCash And Equivalents$168.4MTotal Current Assets$397.1MTotal Current Liabilities$6.7M
Market Cap$4.4B

Current Liabilities

MetricQ2 '23Q4 '24Q1 '25Q4 '25Q1 '26
Accounts payable———$2.1M$1.1M
Accrued Liabilities, Current———$7.0M$5.6M
Other accrued liabilities———$47.0K$39.0K
Total current liabilities———$9.2M$6.7M

Equity

MetricQ2 '23Q4 '24Q1 '25Q4 '25Q1 '26
Additional paid-in capital———$2.3M$543.0M
Accumulated other comprehensive income (loss)———$60.0K-$524.0K
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively———$1.0K$1.0K
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding———$0.0$0.0
Stockholders' Equity Note, Subscriptions Receivable———$0.0$1.2M
Temporary Equity, Shares Subscribed but Unissued, Subscriptions Receivable—$3.8M$3.5M$1.8M$0.0
Retained earnings———-$123.4M-$150.7M
Total liabilities and stockholders' equity———$152.6M$397.4M
Total stockholders' equity—-$48.5M-$60.7M-$121.0M$390.6M

Current Assets

MetricQ2 '23Q4 '24Q1 '25Q4 '25Q1 '26
Available-for-Sale Debt Securities - Single Maturity Date———$140.3M$389.6M
Cash and cash equivalents—$53.1M$32.4M$21.8M$168.4M
Available For Sale Securities Debt Securities Current———$120.1M$222.4M
Other current assets———$307.0K$602.0K
Prepaid expenses and other current assets———$10.6M$6.3M
Short-term investments———$120.1M$222.4M
Total current assets———$152.5M$397.1M

Non-Current Assets

MetricQ2 '23Q4 '24Q1 '25Q4 '25Q1 '26
Operating lease right-of-use assets———$103.0K$266.0K
Property and equipment, net———$22.0K$21.0K
Total assets———$152.6M$397.4M
Total noncurrent assets———$125.0K$287.0K

Non-Current Liabilities

MetricQ2 '23Q4 '24Q1 '25Q4 '25Q1 '26
Operating lease liabilities, non-current———$4.0K$0.0
Total liabilities———$9.2M$6.7M

Other

MetricQ2 '23Q4 '24Q1 '25Q4 '25Q1 '26
Accrued bonuses———$1.9M$563.0K
Professional service fees———$4.3M$3.0M
Research and development———$702.0K$2.0M
Total———$140.2M$390.1M
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10———$0.0$0.0
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10———$0.0$0.0
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five———$26.2M$100.7M
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five———$26.3M$100.3M
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10———$0.0$0.0
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10———$0.0$0.0
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One———$114.0M$289.4M
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One———$114.0M$289.3M
Common stock, par value (in dollars per share)———$0.00$0.00
Common stock, shares authorized (in shares)18M98.8M—267.5M200M
Common stock, shares issued (in shares)———749.8K37.3M
Common Stock, Shares, Outstanding———749.8K37.3M
Number of votes per share of common stock————1.00
Accrued interest available-for-sale debt securities———$900.0K$1.9M
Debt Securities, Available-for-Sale, Unrealized Loss Position———$9.6M$267.4M
Other contract costs———$3.4M$0.0
Tax receivable within other current assets———$1.3M$1.2M
Interest receivable on interest rate and cross currency swaps———$43.0K$438.0K
Preferred stock, automatic conversion, conversion price multiplier———1.20—
Preferred stock, automatic conversion, minimum public common stock offering proceeds———$100.0M—
Preferred Stock, Par or Stated Value Per Share———$0.00$0.00
Preferred Stock, Shares Authorized———025M
Preferred Stock, Shares Issued———00
Preferred Stock, Shares Outstanding———00
Prepaid Insurance———$31.0K$759.0K
Prepaid research and development———$5.6M$3.3M
Exercise price, percentage of fair market value at grant date, minimum————1.00